» Authors » Brynjar Vidarsson

Brynjar Vidarsson

Explore the profile of Brynjar Vidarsson including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 36
Citations 236
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Rognvaldsson S, Gasparini A, Thorsteinsdottir S, Sverrisdottir I, Eythorsson E, Long T, et al.
Br J Haematol . 2024 Dec; 206(3):899-906. PMID: 39721598
Monoclonal gammopathy of undetermined significance (MGUS) is the asymptomatic precursor of multiple myeloma and related diseases but has also been associated with thrombosis. Prior studies have not been based on...
2.
Jonsdottir A, Sigurjonsdottir H, Sigurjonsdottir Prof H, Thorsteinsdottir S, Long T, Sverrisdottir I, et al.
Blood . 2024 Dec; 145(9):970-974. PMID: 39700506
Hypercalcemia in monoclonal gammopathy of undetermined significance (MGUS) presents a clinical challenge because it may indicate progression to multiple myeloma (MM) but could also be due to a multitude of...
3.
Oskarsson J, Rognvaldsson S, Thorsteinsdottir S, Long T, Olafsson A, Eythorsson E, et al.
Blood Cancer J . 2024 Dec; 14(1):221. PMID: 39695077
Light-chain (LC) monoclonal gammopathy of undetermined significance (MGUS) is a precursor of multiple myeloma (MM) and related conditions. LC-MGUS is characterized by free light-chain (FLC) levels outside defined reference intervals,...
4.
Hermouet S, Mennesson N, Allain-Maillet S, Bigot-Corbel E, Olafsson A, Vidarsson B, et al.
Hemasphere . 2024 Dec; 8(12):e70053. PMID: 39670186
No abstract available.
5.
Rognvaldsson S, Oskarsson J, Thorsteinsdottir S, Hultcrantz M, Palmason R, Sverrisdottir I, et al.
Hemasphere . 2024 Nov; 8(11):e70046. PMID: 39564537
Monoclonal gammopathy of undetermined significance (MGUS) is the precursor of multiple myeloma (MM) and related disorders. MGUS is characterized by asymptomatic paraproteinemia. In some cases, multiple paraproteins can be identified...
6.
Kristjansdottir K, Norddahl G, Ivarsdottir E, Halldorsson G, Einarsson G, Bjarnadottir K, et al.
J Allergy Clin Immunol . 2024 Oct; 155(1):228-235. PMID: 39423878
Background: Signal transducer and activator of transcription 6 (STAT6) is central to type 2 (T2) inflammation, and common noncoding variants at the STAT6 locus associate with various T2 inflammatory traits,...
7.
Sharma D, Ungar B, Adalsteinsson J, Sigurdsson J, Sharp K, Thorsteinsdottir S, et al.
Arch Dermatol Res . 2024 Sep; 316(9):627. PMID: 39276205
No abstract available.
8.
Sverrisdottir I, Thorsteinsdottir S, Rognvaldsson S, Aspelund T, Vidarsson B, Onundarson P, et al.
Ann Intern Med . 2024 May; 177(6):711-718. PMID: 38768457
Background: Monoclonal gammopathy of undetermined significance (MGUS) is a precursor of multiple myeloma (MM) and related conditions. In previous registry-based, retrospective studies, autoimmune diseases have been associated with MGUS. However,...
9.
Eythorsson E, Rognvaldsson S, Thorsteinsdottir S, Long T, Reed E, Sigurdardottir G, et al.
Ann Intern Med . 2024 Apr; 177(4):449-457. PMID: 38560901
Background: Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM) are asymptomatic precursor conditions to multiple myeloma and related disorders. Smoldering multiple myeloma is distinguished from MGUS by...
10.
Rognvaldsson S, Thorsteinsdottir S, Syriopoulou E, Sverrisdottir I, Turesson I, Eythorsson E, et al.
Haematologica . 2024 Jan; 109(7):2250-2255. PMID: 38205512
There is some evidence that a prior cancer is a risk factor for the development of multiple myeloma (MM). If this is true, prior cancer should be associated with a...